Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gynecologic 1

Conditions

Fasting 9Prostatic Neoplasms 3Breast Neoplasms 3Intermittent Fasting 2Colorectal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Sarcoma 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasms 1Lymphoma 1Liposarcoma 1Infertility 1Histiocytoma, Malignant Fibrous 1Glioma 1Fibrosis 1Fasting in Malignant Solid Tumors 1Esophageal Neoplasms 1Dermatofibrosarcoma 1Childhood Cancer Survivors 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Angptl4 protein, mouse × Clear all
NCT06536881 2025-08-17

GAMMER

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Recruiting
30 enrolled
Breast

Breast Neoplasms

NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown
150 enrolled
BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

NCT04330339 2022-07-21

Prolonged Nightly Fasting in Breast Cancer Survivors

Massachusetts General Hospital

Phase NA Completed
40 enrolled
Breast

Breast Neoplasms, Fasting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡